Temat: "Finland" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Medical and midwifery students need increased sexual medicine education to overcome barriers hindering bringing up sexual health issues - A national study of final-year medical and midwifery students in Finland.
Autorzy:: Manninen SM; Department of Obstetrics and Gynecology, University of Turku, Turku, Finland; Department of Health Promotion, Metropolia University of Applied Sciences, Helsinki, Finland. Electronic address: .
Kero K; Department of Obstetrics and Gynecology, Turku University Hospital and University of Turku, Turku, Finland.
Riskumäki M; Department of Clinical Medicine, Biostatistics, University of Turku, Turku, Finland.
Vahlberg T; Department of Clinical Medicine, Biostatistics, University of Turku, Turku, Finland.
Polo-Kantola P; Department of Obstetrics and Gynecology, Turku University Hospital and University of Turku, Turku, Finland.; Pokaż więcej
Źródło:: European journal of obstetrics, gynecology, and reproductive biology [Eur J Obstet Gynecol Reprod Biol] 2022 Dec; Vol. 279, pp. 112-117. Date of Electronic Publication: 2022 Oct 29.
Typ publikacji:: Journal Article
MeSH Terms:: Midwifery*/education
Students, Nursing*
Sexual Health*
Students, Medical*
Pregnancy ; Humans ; Female ; Finland ; Clinical Competence

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 2.

Tytuł:: Association of travel time with mental health service use in primary health care according to contact type - a register-based study in Kainuu, Finland.
Autorzy:: Lankila T; Geography Research Unit, University of Oulu, P.O Box 8000, 90014, Oulu, Finland. .
Laatikainen T; Department of Public Health and Social Welfare, Finnish Institute for Health and Welfare, P.O. Box 30, 00271, Helsinki, Finland.; Institute of Public Health and Clinical Nutrition, University of Eastern Finland, P.O. Box 1627, 70211, Kuopio, Finland.; Joint Municipal Authority for North Karelia Social and Health Services, (Siun Sote), Tikkamäentie 16, 80210, Joensuu, Finland.
Wikström K; Department of Public Health and Social Welfare, Finnish Institute for Health and Welfare, P.O. Box 30, 00271, Helsinki, Finland.; Institute of Public Health and Clinical Nutrition, University of Eastern Finland, P.O. Box 1627, 70211, Kuopio, Finland.
Linna M; Department of Health and Social Care Management, University of Eastern Finland, P.O. Box 1627, 70211, Kuopio, Finland.; Institute of Healthcare Engineering, management and architecture, Aalto University, Espoo, Finland.
Antikainen H; Geography Research Unit, University of Oulu, P.O Box 8000, 90014, Oulu, Finland.; Pokaż więcej
Źródło:: BMC health services research [BMC Health Serv Res] 2022 Nov 30; Vol. 22 (1), pp. 1458. Date of Electronic Publication: 2022 Nov 30.
Typ publikacji:: Journal Article
MeSH Terms:: Mental Health Services*
Mental Disorders*/epidemiology
Mental Disorders*/therapy
Adult ; Humans ; Finland/epidemiology ; Travel ; Primary Health Care

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 3.

Tytuł:: Residential history and changes in perceived health-The Northern Finland Birth Cohort 1966 study.
Autorzy:: Lankila T; The Geography Research Unit, Faculty of Science, University of Oulu, PO Box 3000, 90014, Oulu, Finland; Department of Sports and Exercise Medicine, Oulu Deaconess Institute Foundation sr., PO Box 365, 90100, Oulu, Finland. Electronic address: .
Puhakka S; The Geography Research Unit, Faculty of Science, University of Oulu, PO Box 3000, 90014, Oulu, Finland; Department of Sports and Exercise Medicine, Oulu Deaconess Institute Foundation sr., PO Box 365, 90100, Oulu, Finland.
Kärmeniemi M; Research Unit of Population Health, Faculty of Medicine, University of Oulu, PO Box 5000, 90014, Oulu, Finland.
Kangas M; Northern Finland Birth Cohorts, Arctic Biobank, Infrastructure for Population Studies, Faculty of Medicine, University of Oulu, Oulu, Finland.
Rusanen J; The Geography Research Unit, Faculty of Science, University of Oulu, PO Box 3000, 90014, Oulu, Finland.
Korpelainen R; Department of Sports and Exercise Medicine, Oulu Deaconess Institute Foundation sr., PO Box 365, 90100, Oulu, Finland; Research Unit of Population Health, Faculty of Medicine, University of Oulu, PO Box 5000, 90014, Oulu, Finland; Medical Research Center Oulu, Oulu University Hospital and University of Oulu, PO Box 5000, 90014, Oulu, Finland.; Pokaż więcej
Źródło:: Health & place [Health Place] 2022 Nov; Vol. 78, pp. 102931. Date of Electronic Publication: 2022 Nov 03.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Birth Cohort*
Residence Characteristics*
Middle Aged ; Male ; Humans ; Finland/epidemiology ; Cohort Studies ; Health Status

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 4.

Tytuł:: Asymmetric and long-run impact of political stability on consumption-based carbon dioxide emissions in Finland: Evidence from nonlinear and Fourier-based approaches.
Autorzy:: Kartal MT; Borsa Istanbul Strategic Planning, Financial Reporting, and Investor Relations Directorate, Reşitpaşa Mahallesi Borsa İstanbul Caddesi No: 4 34467, Sarıyer, Istanbul, Turkey. Electronic address: .
Depren SK; Yildiz Technical University, Department of Statistics, Istanbul, Turkey. Electronic address: .
Kirikkaleli D; European University of Lefke, Faculty of Economic and Administrative Sciences, Department of Banking and Finance, Lefke/Northern Cyprus, via, Mersin, Turkey. Electronic address: .
Depren Ö; Yapı Kredi Bank Customer Experience Research Lab., Istanbul, Turkey. Electronic address: .
Khan U; College of Business Administration, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi Arabia. Electronic address: .; Pokaż więcej
Źródło:: Journal of environmental management [J Environ Manage] 2022 Nov 01; Vol. 321, pp. 116043. Date of Electronic Publication: 2022 Aug 26.
Typ publikacji:: Journal Article
MeSH Terms:: Carbon Dioxide*/analysis
Economic Development*
Finland ; Renewable Energy

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 5.

Tytuł:: Comorbidity characteristics of multiple myeloma patients diagnosed in Finland 2005-2016.
Autorzy:: Toppila I; Medaffcon Oy, Espoo, Finland. .
Kysenius K; Medaffcon Oy, Espoo, Finland.
Miettinen T; Medaffcon Oy, Espoo, Finland.; Takeda Oy, Helsinki, Finland.
Lassenius MI; Medaffcon Oy, Espoo, Finland.
Lievonen J; Department of Hematology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Anttila P; Department of Hematology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Pokaż więcej
Źródło:: Annals of hematology [Ann Hematol] 2022 Nov; Vol. 101 (11), pp. 2485-2495. Date of Electronic Publication: 2022 Sep 13.
Typ publikacji:: Journal Article
MeSH Terms:: Cardiovascular Diseases*/epidemiology
Multiple Myeloma*/diagnosis
Multiple Myeloma*/epidemiology
Adult ; Aged ; Comorbidity ; Finland/epidemiology ; Humans ; Male ; Registries ; Retrospective Studies ; Risk Factors

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 6.

Tytuł:: Genome-wide association study of varicose veins identifies a protective missense variant in GJD3 enriched in the Finnish population.
Autorzy:: Helkkula P; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
Hassan S; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
Saarentaus E; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
Vartiainen E; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
Ruotsalainen S; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
Leinonen JT; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
Palotie A; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.; Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
Karjalainen J; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.; Broad Institute of the Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.
Kurki M; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.; Broad Institute of the Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.
Ripatti S; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.; Broad Institute of the Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Department of Public Health, Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Tukiainen T; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland. .; Pokaż więcej
Corporate Authors:: FinnGen
Źródło:: Communications biology [Commun Biol] 2023 Jan 18; Vol. 6 (1), pp. 71. Date of Electronic Publication: 2023 Jan 18.
Typ publikacji:: Journal Article
MeSH Terms:: Genome-Wide Association Study*
Varicose Veins*/epidemiology
Varicose Veins*/genetics
Humans ; Female ; Finland/epidemiology ; Chronic Disease ; Connexins/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Birth order and sickness absence: Register-based evidence from Finland.
Autorzy:: Reini K; Demography Unit, Faculty of Education and Welfare Studies, Åbo Akademi University, Vaasa, Finland.
Saarela J; Demography Unit, Faculty of Education and Welfare Studies, Åbo Akademi University, Vaasa, Finland.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Jan 17; Vol. 18 (1), pp. e0280532. Date of Electronic Publication: 2023 Jan 17 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: Birth Order*
Musculoskeletal Diseases*/epidemiology
Male ; Humans ; Female ; Child ; Adult ; Follow-Up Studies ; Finland/epidemiology ; Income ; Sick Leave

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Seroprevalence of polyomaviruses BK and JC in Finnish women and their spouses followed-up for three years.
Autorzy:: Laine HK; Department of Oral and Maxillofacial Diseases, Faculty of Medicine, University of Helsinki, P.O. Box 41, 00014, Helsinki, Finland. .; Department of Oral Pathology and Radiology, Faculty of Medicine, University of Turku, Turku, Finland. .
Waterboer T; Division of Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Syrjänen K; SMW Consultants Ltd, Kaarina, Finland.
Grenman S; Department of Obstetrics and Gynecology, University of Turku, Turku University Hospital, Turku, Finland.
Louvanto K; Department of Obstetrics and Gynecology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland.
Syrjänen S; Department of Oral Pathology and Radiology, Faculty of Medicine, University of Turku, Turku, Finland.; Department of Pathology, University of Turku, Turku University Hospital, Turku, Finland.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Jan 17; Vol. 13 (1), pp. 879. Date of Electronic Publication: 2023 Jan 17.
Typ publikacji:: Journal Article
MeSH Terms:: JC Virus*
BK Virus*
Polyomavirus Infections*
Humans ; Male ; Female ; Pregnancy ; Finland/epidemiology ; Seroepidemiologic Studies ; Spouses

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: A retrospective nationwide register-based study to evaluate the non-specific effects of first MMR vaccination among children in Finland.
Autorzy:: Palmu AAM; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Tampere, Finland.
Nieminen H; Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Tampere, Finland. Electronic address: .
Lahdenkari M; Department of Information Services, Finnish Institute for Health and Welfare, Helsinki, Finland.
Palmu AA; Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Tampere, Finland.; Pokaż więcej
Źródło:: Vaccine [Vaccine] 2023 Jan 16; Vol. 41 (3), pp. 805-811. Date of Electronic Publication: 2022 Dec 14.
Typ publikacji:: Journal Article
MeSH Terms:: Measles*/epidemiology
Measles*/prevention & control
Rubella*/prevention & control
Mumps*/epidemiology
Mumps*/prevention & control
Male ; Female ; Humans ; Child ; Infant ; Finland/epidemiology ; Retrospective Studies ; Cohort Studies ; Measles-Mumps-Rubella Vaccine ; Vaccination

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 10.

Tytuł:: Efficacy and effectiveness of case isolation and quarantine during a growing phase of the COVID-19 epidemic in Finland.
Autorzy:: Auranen K; Department of Mathematics and Statistics, University of Turku, Vesilinnankatu 5, 20014, Turku, Finland. .; Department of Clinical Medicine, University of Turku, Vesilinnankatu 5, 20014, Turku, Finland. .; Department of Health Security, Finnish Institute for Health and Welfare, Mannerheimintie 166, 00271, Helsinki, Finland. .
Shubin M; Department of Health Security, Finnish Institute for Health and Welfare, Mannerheimintie 166, 00271, Helsinki, Finland.
Erra E; Epidemiological Operations Unit, City of Helsinki, Toinen linja 4 A, P.O. Box 6008, 00530, Helsinki, Finland.
Isosomppi S; Epidemiological Operations Unit, City of Helsinki, Toinen linja 4 A, P.O. Box 6008, 00530, Helsinki, Finland.
Kontto J; Department of Health Security, Finnish Institute for Health and Welfare, Mannerheimintie 166, 00271, Helsinki, Finland.; Epidemiological Operations Unit, City of Helsinki, Toinen linja 4 A, P.O. Box 6008, 00530, Helsinki, Finland.
Leino T; Department of Health Security, Finnish Institute for Health and Welfare, Mannerheimintie 166, 00271, Helsinki, Finland.
Lukkarinen T; Epidemiological Operations Unit, City of Helsinki, Toinen linja 4 A, P.O. Box 6008, 00530, Helsinki, Finland.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Jan 06; Vol. 13 (1), pp. 298. Date of Electronic Publication: 2023 Jan 06.
Typ publikacji:: Journal Article
MeSH Terms:: COVID-19*/epidemiology
COVID-19*/prevention & control
Humans ; Quarantine ; SARS-CoV-2 ; Finland/epidemiology ; Contact Tracing

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Association of income and educational levels on initiation of oral anticoagulant therapy in patients with incident atrial fibrillation: A Finnish nationwide cohort study.
Autorzy:: Teppo K; University of Turku, Turku, Finland.
Jaakkola J; University of Turku, Turku, Finland.; Heart Unit, Satakunta Central Hospital, Pori, Finland.
Biancari F; Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland.; Clinica Montevergine, GVM Care & Research, Mercogliano, Italy.
Halminen O; Department of Industrial Engineering and Management, Aalto University, Espoo, Finland.
Linna M; Aalto University, Espoo, Finland.; University of Eastern Finland, Kuopio, Finland.
Haukka J; University of Helsinki, Faculty of Medicine, Clinicum, Helsinki, Finland.
Putaala J; Neurology, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland.
Mustonen P; Heart Center, Turku University Hospital, Turku, Finland.
Kinnunen J; Neurology, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland.
Hartikainen J; University of Eastern Finland, Kuopio, Finland.; Heart Center, Kuopio University Hospital, Kuopio, Finland.
Airaksinen KEJ; University of Turku, Turku, Finland.; Heart Center, Turku University Hospital, Turku, Finland.
Lehto M; Department of Industrial Engineering and Management, Aalto University, Espoo, Finland.; University of Helsinki, Faculty of Medicine, Clinicum, Helsinki, Finland.; Department of Internal Medicine, Lohja Hospital, Lohja, Finland.; Pokaż więcej
Źródło:: British journal of clinical pharmacology [Br J Clin Pharmacol] 2023 Jan; Vol. 89 (1), pp. 351-360. Date of Electronic Publication: 2022 Sep 05.
Typ publikacji:: Journal Article
MeSH Terms:: Atrial Fibrillation*/drug therapy
Stroke*/prevention & control
Humans ; Female ; Middle Aged ; Aged ; Aged, 80 and over ; Male ; Cohort Studies ; Finland ; Anticoagulants/adverse effects ; Educational Status ; Administration, Oral ; Risk Factors

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 12.

Tytuł:: How Adolescents and Parents See Their Moral Responsibilities With Regard to Adolescents Using Alcohol-A Deductive Secondary Analysis.
Autorzy:: Mynttinen MA; Department of Nursing Science, Faculty of Medicine, University of Turku, 20014 Turku, Finland; Nursing Degree Program, Karelia University of Applied Sciences, 80200, Joensuu, Finland.
Mishina KE; Departments of Nursing Science and Child Psychiatry, Faculty of Medicine, University of Turku, 20014 Turku, Finland, INVEST Research Flagship Center, Turku, Finland.
Kangasniemi MK; Department of Nursing Science, Faculty of Medicine, University of Turku, 20014, Turku, Finland.; Pokaż więcej
Źródło:: The Journal of school health [J Sch Health] 2023 Jan; Vol. 93 (1), pp. 62-72. Date of Electronic Publication: 2022 Oct 17.
Typ publikacji:: Journal Article
MeSH Terms:: Parents*
Schools*
Child ; Humans ; Adolescent ; Finland ; Health Status ; Research Design

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 13.

Tytuł:: Accuracy of dispatch and prehospital triage performance in poisonings - A retrospective study from northern Finland.
Autorzy:: Koskela L; Research Group of Surgery, Anesthesiology and Intensive Care Medicine, Medical Research Center Oulu, Oulu, Finland.
Raatiniemi L; Centre for prehospital emergency care, Oulu University Hospital, Oulu, Finland.
Ehrola A; Emergency Medical Services, Northern Ostrobothnian Hospital District, Oulu, Finland.
Kaakinen T; Research Group of Surgery, Anesthesiology and Intensive Care Medicine, Medical Research Center Oulu, Oulu, Finland.; Department of Anesthesiology, Oulu University Hospital, Oulu, Finland.
Lahtinen S; Research Group of Surgery, Anesthesiology and Intensive Care Medicine, Medical Research Center Oulu, Oulu, Finland.; Department of Anesthesiology, Oulu University Hospital, Oulu, Finland.
Liisanantti J; Research Group of Surgery, Anesthesiology and Intensive Care Medicine, Medical Research Center Oulu, Oulu, Finland.; Department of Anesthesiology, Oulu University Hospital, Oulu, Finland.; Pokaż więcej
Źródło:: Acta anaesthesiologica Scandinavica [Acta Anaesthesiol Scand] 2023 Jan; Vol. 67 (1), pp. 112-119. Date of Electronic Publication: 2022 Oct 12.
Typ publikacji:: Journal Article
MeSH Terms:: Triage*/methods
Emergency Medical Services*/methods
Humans ; Retrospective Studies ; Finland/epidemiology ; Hospitals

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 14.

Tytuł:: The association between dental caries and physical activity, physical fitness, and background factors among Finnish male conscripts.
Autorzy:: Huttunen M; Department of Cariology, Endodontology and Pediatric Dentistry, Research Unit of Oral Health Sciences, University of Oulu, P.O. Box 5281, FI-90014, Oulu, Finland.; Centre for Military Medicine, Finnish Defence Forces, P.O. Box 5, 11311, Riihimäki, Finland.
Kämppi A; Department of Oral and Maxillofacial Diseases, University of Helsinki, P.O. Box 41, 00014, Helsinki, Finland.
Soudunsaari A; Department of Cariology, Endodontology and Pediatric Dentistry, Research Unit of Oral Health Sciences, University of Oulu, P.O. Box 5281, FI-90014, Oulu, Finland.
Päkkilä J; Department of Mathematical Sciences, University of Oulu, P.O. Box 8000, 90014, Oulu, Finland.
Tjäderhane L; Department of Cariology, Endodontology and Pediatric Dentistry, Research Unit of Oral Health Sciences, University of Oulu, P.O. Box 5281, FI-90014, Oulu, Finland.; Department of Oral and Maxillofacial Diseases, University of Helsinki, P.O. Box 41, 00014, Helsinki, Finland.; MRC, Oulu University Hospital and University of Oulu, P.O. Box 5281, 90014, Oulu, Finland.; Helsinki University Hospital, P.O. Box 41, 00014, Helsinki, Finland.
Laitala ML; Department of Cariology, Endodontology and Pediatric Dentistry, Research Unit of Oral Health Sciences, University of Oulu, P.O. Box 5281, FI-90014, Oulu, Finland.; MRC, Oulu University Hospital and University of Oulu, P.O. Box 5281, 90014, Oulu, Finland.
Anttonen V; Department of Cariology, Endodontology and Pediatric Dentistry, Research Unit of Oral Health Sciences, University of Oulu, P.O. Box 5281, FI-90014, Oulu, Finland.; MRC, Oulu University Hospital and University of Oulu, P.O. Box 5281, 90014, Oulu, Finland.
Patinen P; Centre for Military Medicine, Finnish Defence Forces, P.O. Box 5, 11311, Riihimäki, Finland.
Tanner T; Department of Cariology, Endodontology and Pediatric Dentistry, Research Unit of Oral Health Sciences, University of Oulu, P.O. Box 5281, FI-90014, Oulu, Finland. .; MRC, Oulu University Hospital and University of Oulu, P.O. Box 5281, 90014, Oulu, Finland. .; Pokaż więcej
Źródło:: Odontology [Odontology] 2023 Jan; Vol. 111 (1), pp. 192-200. Date of Electronic Publication: 2022 May 25.
Typ publikacji:: Journal Article
MeSH Terms:: Dental Caries*/epidemiology
Exercise*
Physical Fitness*
Humans ; Male ; Finland/epidemiology ; Oral Health ; Prevalence

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 15.

Tytuł:: A summary of the first 100 neurointerventional procedures performed with the Rist radial access device in a Finnish neurovascular center.
Autorzy:: Rautio R; Department of Radiology, Turku University Hospital, Finland. Electronic address: .
Alpay K; Department of Radiology, Turku University Hospital, Finland.
Rahi M; Department of Neurosurgery, Turku University Hospital, Finland.
Sinisalo M; Department of Radiology, Turku University Hospital, Finland.; Pokaż więcej
Źródło:: European journal of radiology [Eur J Radiol] 2023 Jan; Vol. 158, pp. 110604. Date of Electronic Publication: 2022 Nov 26.
Typ publikacji:: Journal Article
MeSH Terms:: Endovascular Procedures*/methods
Embolization, Therapeutic*/methods
Humans ; Radial Artery/diagnostic imaging ; Radial Artery/surgery ; Retrospective Studies ; Finland ; Treatment Outcome

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 16.

Tytuł:: Working life expectancy and working years lost among users of part- and full-time sickness absence in Finland.
Autorzy:: Hartikainen E; The Finnish Institute of Occupational Health, P.O. Box 40, 00032 TYÖTERVEYSLAITOS, Finland. .
Solovieva S
Viikari-Juntura E
Leinonen T; Pokaż więcej
Źródło:: Scandinavian journal of work, environment & health [Scand J Work Environ Health] 2023 Jan 01; Vol. 49 (1), pp. 23-32. Date of Electronic Publication: 2022 Aug 26.
Typ publikacji:: Journal Article
MeSH Terms:: Employment*
Musculoskeletal Diseases*/epidemiology
Humans ; Male ; Female ; Adult ; Finland/epidemiology ; Unemployment ; Life Expectancy ; Sick Leave

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 17.

Tytuł:: Epidemiology and aetiology of sport-related nasal fractures: Analysis of 599 Finnish patients.
Autorzy:: Manninen IK; Department of Otorhinolaryngology-Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Klockars T; Department of Otorhinolaryngology-Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Mäkinen LK; Department of Pulmonary Medicine, Heart and Lung Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Blomgren K; HUS Joint Resources, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.; Pokaż więcej
Źródło:: Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery [Clin Otolaryngol] 2023 Jan; Vol. 48 (1), pp. 70-74. Date of Electronic Publication: 2022 Sep 09.
Typ publikacji:: Journal Article
MeSH Terms:: Skull Fractures*/surgery
Nose Diseases*
Nose Deformities, Acquired*
Humans ; Finland/epidemiology ; Nasal Bone ; Facial Bones ; Nasal Septum

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 18.

Tytuł:: Higher odds of gestational diabetes among women with multiple pregnancies: a nationwide register-based cohort study in Finland.
Autorzy:: Vaajala M; Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland. .
Liukkonen R; Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Ponkilainen V; Department of Surgery, Central Finland Central Hospital Nova, Jyväskylä, Finland.
Kekki M; Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland.; Center for Child, Adolescent and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Mattila VM; Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.; Department of Orthopaedics and Traumatology, Tampere University Hospital Tampere, Tampere, Finland.
Kuitunen I; Department of Pediatrics, Mikkeli Central Hospital, Mikkeli, Finland.; Institute of Clinical Medicine and Department of Pediatrics, University of Eastern Finland, Kuopio, Finland.; Pokaż więcej
Źródło:: Acta diabetologica [Acta Diabetol] 2023 Jan; Vol. 60 (1), pp. 127-130. Date of Electronic Publication: 2022 Oct 11.
Typ publikacji:: Journal Article
MeSH Terms:: Diabetes, Gestational*/epidemiology
Diabetes, Gestational*/diagnosis
Pregnancy ; Female ; Humans ; Cohort Studies ; Retrospective Studies ; Finland/epidemiology ; Risk Factors ; Pregnancy, Multiple

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 19.

Tytuł:: Serum copper and the risk of cardiovascular disease death in Finnish men.
Autorzy:: Isiozor NM; Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland. Electronic address: .
Kunutsor SK; National Institute for Health Research Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, United Kingdom; Translational Health Sciences, Bristol Medical School, Musculoskeletal Research Unit, University of Bristol, United Kingdom.
Vogelsang D; Faculty of Health, Medicine and Life Sciences, Maastricht University, Netherlands.
Isiozor I; Federal Medical Centre, Owerri, Nigeria.
Kauhanen J; Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
Laukkanen JA; Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland; Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland; Central Finland Health Care District, Department of Internal Medicine, Jyvaskyla, Finland.; Pokaż więcej
Źródło:: Nutrition, metabolism, and cardiovascular diseases : NMCD [Nutr Metab Cardiovasc Dis] 2023 Jan; Vol. 33 (1), pp. 151-157. Date of Electronic Publication: 2022 Oct 05.
Typ publikacji:: Journal Article
MeSH Terms:: Cardiovascular Diseases*/etiology
Middle Aged ; Male ; Humans ; Aged ; Prospective Studies ; Copper ; Finland/epidemiology ; Risk Factors ; Obesity/diagnosis ; Obesity/complications

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 20.

Tytuł:: FinnGen provides genetic insights from a well-phenotyped isolated population.
Autorzy:: Kurki MI; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
Karjalainen J; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
Palta P; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.
Sipilä TP; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Kristiansson K; Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Donner KM; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Reeve MP; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Laivuori H; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Medical and Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland.; Faculty of Medicine and Health Technology, Center for Child, Adolescent and Maternal Health, University of Tampere, Tampere, Finland.
Aavikko M; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Kaunisto MA; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Loukola A; Helsinki Biobank, University of Helsinki and Hospital District of Helsinki and Uusimaa, Helsinki, Finland.
Lahtela E; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Mattsson H; Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Laiho P; Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Della Briotta Parolo P; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Lehisto AA; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Kanai M; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Mars N; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Rämö J; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Kiiskinen T; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Heyne HO; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Digital Health Center, Hasso Plattner Institute for Digital Engineering, University of Potsdam Potsdam, Potsdam, Germany.; Hasso Plattner Institute for Digital Health at Mount Sinai, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Veerapen K; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
Rüeger S; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Lemmelä S; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Zhou W; Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
Ruotsalainen S; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Pärn K; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Hiekkalinna T; Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Koskelainen S; Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Paajanen T; Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Llorens V; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Gracia-Tabuenca J; TAUCHI Research Center, Faculty of Information Technology and Communication Sciences, Tampere University, Tampere, Finland.
Siirtola H; TAUCHI Research Center, Faculty of Information Technology and Communication Sciences, Tampere University, Tampere, Finland.
Reis K; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.
Elnahas AG; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.
Sun B; Translational Biology, Research and Development, Biogen, Cambridge, MA, USA.; BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Foley CN; Optima Partners, Edinburgh, UK.; MRC Biostatistics Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Aalto-Setälä K; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Alasoo K; Institute of Computer Science, University of Tartu, Tartu, Estonia.
Arvas M; Finnish Red Cross Blood Service, Helsinki, Finland.
Auro K; GlaxoSmithKline, Espoo, Finland.
Biswas S; Bristol Myers Squibb, New York, NY, USA.
Bizaki-Vallaskangas A; Tampere University Hospital and Tampere University, Tampere, Finland.
Carpen O; Helsinki Biobank, University of Helsinki and Hospital District of Helsinki and Uusimaa, Helsinki, Finland.
Chen CY; Biogen, Cambridge, MA, USA.
Dada OA; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Ding Z; Boehringer Ingelheim, Ingelheim am Rhein, Germany.
Ehm MG; GlaxoSmithKline, Collegeville, PA, USA.
Eklund K; Division of Rheumatology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland.; Orton Orthopedic Hospital, Helsinki, Finland.
Färkkilä M; Abdominal Center, Helsinki University Hospital, Helsinki University, Helsinki, Finland.
Finucane H; Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
Ganna A; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
Ghazal A; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Graham RR; Maze Therapeutics, South San Francisco, CA, USA.
Green EM; Maze Therapeutics, South San Francisco, CA, USA.
Hakanen A; Auria Biobank, University of Turku and Turku University Hospital, Turku, Finland.
Hautalahti M; FINBB, Finnish Biobank Cooperative, Helsinki, Finland.
Hedman ÅK; Pfizer, New York, NY, USA.; Department of Medicine, Karolinska Institute, Solna, Sweden.
Hiltunen M; Clinical Biobank Tampere, Tampere University and Tampere University Hospital, Tampere, Finland.
Hinttala R; Medical Research Center Oulu and PEDEGO Research Unit, University of Oulu, Oulu, Finland.; Biocenter Oulu, University of Oulu, Oulu, Finland.; Oulu University Hospital, Oulu, Finland.
Hovatta I; Department of Psychology and Logopedics, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; SleepWell Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Hu X; Pfizer, New York, NY, USA.
Huertas-Vazquez A; Merck & Co, Kenilworth, NJ, USA.
Huilaja L; PEDEGO Research Unit, University of Oulu, Oulu, Finland.; Department of Dermatology and Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland.
Hunkapiller J; Genentech, San Francisco, CA, USA.
Jacob H; AbbVie, Chicago, IL, USA.
Jensen JN; Boehringer Ingelheim, Ingelheim am Rhein, Germany.
Joensuu H; Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
John S; Biogen, Cambridge, MA, USA.
Julkunen V; Neuro Center, Neurology, Kuopio University Hospital, Kuopio, Finland.; Institute of Clinical Medicine-Neurology, University of Eastern Finland, Kuopio, Finland.
Jung M; Boehringer Ingelheim, Ingelheim am Rhein, Germany.
Junttila J; Northern Finland Biobank Borealis, University of Oulu, Northern Ostrobothnia Hospital District, Oulu, Finland.
Kaarniranta K; Department of Ophthalmology, Kuopio University Hospital, Kuopio, Finland.; Department of Ophthalmology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Kähönen M; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Department of Clinical Physiology, Tampere University Hospital, Tampere, Finland.
Kajanne R; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Kallio L; Auria Biobank, University of Turku and Turku University Hospital, Turku, Finland.
Kälviäinen R; Epilepsy Center, Kuopio University Hospital, Kuopio, Finland.; Department of Neurology, University of Eastern Finland, Kuopio, Finland.
Kaprio J; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Department of Public Health, University of Helsinki, Helsinki, Finland.
Kerimov N; Institute of Computer Science, University of Tartu, Tartu, Estonia.
Kettunen J; Finnish Institute for Health and Welfare (THL), Helsinki, Finland.; Biocenter Oulu, University of Oulu, Oulu, Finland.; Computational Medicine, Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland.
Kilpeläinen E; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Kilpi T; Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Klinger K; Translational Sciences, Sanofi R&D, Framingham, MA, USA.
Kosma VM; Biobank of Eastern Finland, University of Eastern Finland, Kuopio, Finland.; Kuopio University Hospital, Kuopio, Finland.
Kuopio T; Central Finland Biobank, Central Finland Health Care District, Jyväskylä, Finland.
Kurra V; Department of Clinical Genetics, Tampere University Hospital, Tampere, Finland.; Department of Clinical Genetics, Faculty of Medicine and Health Technology, Tampere, Finland.
Laisk T; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.
Laukkanen J; Central Finland Biobank, Central Finland Health Care District, Jyväskylä, Finland.; Department of Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Lawless N; Boehringer Ingelheim, Ingelheim am Rhein, Germany.
Liu A; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Longerich S; Merck & Co, Kenilworth, NJ, USA.
Mägi R; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.
Mäkelä J; FINBB, Finnish Biobank Cooperative, Turku, Finland.
Mäkitie A; Department of Otorhinolaryngology-Head and Neck Surgery, University of Helsinki, Helsinki, Finland.; Helsinki University Hospital, Helsinki, Finland.
Malarstig A; Pfizer, Cambridge, MA, USA.; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Solna, Sweden.
Mannermaa A; Biobank of Eastern Finland, University of Eastern Finland, Kuopio, Finland.; Kuopio University Hospital, Kuopio, Finland.
Maranville J; Bristol Myers Squibb, New York, NY, USA.
Matakidou A; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Meretoja T; Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Mozaffari SV; Maze Therapeutics, South San Francisco, CA, USA.
Niemi MEK; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Niemi M; TAUCHI Research Center, Faculty of Information Technology and Communication Sciences, Tampere University, Tampere, Finland.
Niiranen T; Finnish Institute for Health and Welfare (THL), Helsinki, Finland.; Turku University Hospital and University of Turku, Turku, Finland.
O Donnell CJ; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
Obeidat ME; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
Okafo G; Boehringer Ingelheim, Ingelheim am Rhein, Germany.
Ollila HM; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.
Palomäki A; Turku University Hospital and University of Turku, Turku, Finland.
Palotie T; Department of Oral and Maxillofacial Diseases, Helsinki University Hospital, Helsinki, Finland.; Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland.
Partanen J; Finnish Red Cross Blood Service, Helsinki, Finland.; Finnish Hematological Biobank, Helsinki, Finland.
Paul DS; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Pelkonen M; Department of Pulmonary Diseases, Kuopio University Hospital, Kuopio, Finland.
Pendergrass RK; Genentech, San Francisco, CA, USA.
Petrovski S; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Pitkäranta A; Department of Otorhinolaryngology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Platt A; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Pulford D; GlaxoSmithKline, Stevenage, UK.
Punkka E; Helsinki Biobank, University of Helsinki and Hospital District of Helsinki and Uusimaa, Helsinki, Finland.
Pussinen P; Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland.
Raghavan N; Merck & Co, Kenilworth, NJ, USA.
Rahimov F; AbbVie, Chicago, IL, USA.
Rajpal D; Translational Sciences, Sanofi R&D, Framingham, MA, USA.
Renaud NA; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
Riley-Gillis B; AbbVie, Chicago, IL, USA.
Rodosthenous R; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Saarentaus E; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Salminen A; Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland.
Salminen E; Helsinki University Hospital, Helsinki, Finland.; Department of Clinical Genetics, HUSLAB, HUS Diagnostic Center, University of Helsinki, Helsinki, Finland.
Salomaa V; Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Schleutker J; Auria Biobank, University of Turku and Turku University Hospital, Turku, Finland.
Serpi R; Northern Finland Biobank Borealis, University of Oulu, Northern Ostrobothnia Hospital District, Oulu, Finland.
Shen HY; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Siegel R; Novartis Institutes for BioMedical Research, Basel, Switzerland.
Silander K; Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Siltanen S; Finnish Clinical Biobank Tampere, Tampere University and Tampere University Hospital, Tampere, Finland.
Soini S; Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Soininen H; Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Sul JH; Merck & Co, Kenilworth, NJ, USA.
Tachmazidou I; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Tasanen K; PEDEGO Research Unit, University of Oulu, Oulu, Finland.; Department of Dermatology and Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland.
Tienari P; Department of Neurology, Helsinki University Hospital, Helsinki, Finland.; Translational Immunology, Research Programs Unit, University of Helsinki, Helsinki, Finland.
Toppila-Salmi S; Department of Allergy, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Tukiainen T; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Tuomi T; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Abdominal Center, Endocrinology, Helsinki University Hospital, Helsinki, Finland.; Folkhalsan Research Center, Helsinki, Finland.; Research Program of Clinical and Molecular Metabolism, University of Helsinki, Helsinki, Finland.
Turunen JA; Helsinki University Hospital and University of Helsinki, Helsinki, Finland.; Eye Genetics Group, Folkhälsan Research Center, Helsinki, Finland.
Ulirsch JC; Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Vaura F; Finnish Institute for Health and Welfare (THL), Helsinki, Finland.; University of Turku, Turku, Finland.
Virolainen P; Auria Biobank, University of Turku and Turku University Hospital, Turku, Finland.
Waring J; AbbVie, Chicago, IL, USA.
Waterworth D; Janssen Research & Development, Spring House, PA, USA.
Yang R; Janssen Biotech, Beerse, Belgium.
Nelis M; Genomics Core Facility, Institute of Genomics, University of Tartu, Tartu, Estonia.
Reigo A; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.
Metspalu A; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.
Milani L; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.
Esko T; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.
Fox C; Merck & Co, Kenilworth, NJ, USA.
Havulinna AS; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Perola M; Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Ripatti S; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Jalanko A; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Laitinen T; Finnish Clinical Biobank Tampere, Tampere University and Tampere University Hospital, Tampere, Finland.
Mäkelä TP; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Plenge R; Bristol Myers Squibb, New York, NY, USA.
McCarthy M; Genentech, San Francisco, CA, USA.
Runz H; Biogen, Cambridge, MA, USA.
Daly MJ; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
Palotie A; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland. .; Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA. .; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA, USA. .; Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA. .; Pokaż więcej
Corporate Authors:: FinnGen
Źródło:: Nature [Nature] 2023 Jan; Vol. 613 (7944), pp. 508-518. Date of Electronic Publication: 2023 Jan 18.
Typ publikacji:: Journal Article
MeSH Terms:: Genome-Wide Association Study*
Genetic Predisposition to Disease*/genetics
Humans ; Middle Aged ; Gene Frequency/genetics ; Phenotype ; Finland ; United Kingdom ; Polymorphism, Single Nucleotide/genetics

Czasopismo naukowe

na półce

Szczegóły

Informacja

Wyszukujesz frazę ""Finland"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Starter badań:

Finland.